Cardiological Society of India Practice Guidelines for Angiography in Patients with Renal Dysfunction

Charytan, 2007, Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease, Kidney Int, 71, 938, 10.1038/sj.ki.5002159 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Tonelli, 2006, Chronic kidney disease and mortality risk: a systematic review, J Am Soc Nephrol, 17, 2034, 10.1681/ASN.2005101085 Nash, 2002, Hospital-acquired renal insufficiency, Am J Kidney Dis, 39, 930, 10.1053/ajkd.2002.32766 Drobnie, 1996, Effects of nonionic radiographic contrast media on renal function after cardiac catheterisation, Radiol Oncol, 30, 95 Thomsen, 2003, Guidelines for contrast media from the Europeon Society of Urogenital Radiology, AJR Am J Roentgenol, 181, 1463, 10.2214/ajr.181.6.1811463 Bartholomew, 2004, Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification, Am J Cardiol, 93, 1515, 10.1016/j.amjcard.2004.03.008 Murphy, 2000, Contrast nephropathy, J Am Soc Nephrol, 11, 177, 10.1681/ASN.V111177 Maeder, 2004, Contrast nephropathy: review focusing on prevention, J Am coll Cardiol, 44, 1763, 10.1016/j.jacc.2004.06.075 Goldenberg, 2005, Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies, CMAJ, 172, 1461, 10.1503/cmaj.1040847 Gleeson, 2004, Contrast-induced nephropathy, Am J Roentgenol, 183, 1673, 10.2214/ajr.183.6.01831673 Mehran, 2006, Contrast-induced nephropathy: definition, epidemiology, and patients at risk, Kidney Int Suppl, 100, S11, 10.1038/sj.ki.5000368 Nikolsky, 2005, Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions, Kidney Int, 6, 706, 10.1111/j.1523-1755.2005.67131.x Hall, 1992, Contrast-induced nephrotoxicity: the effects of vasodilator therapy, J Surg Res, 53, 317, 10.1016/0022-4804(92)90054-4 McCullough, 1997, Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality, Am J Med, 103, 368, 10.1016/S0002-9343(97)00150-2 Nikolsky, 2004, Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention, Am J Cardiol, 94, 300, 10.1016/j.amjcard.2004.04.023 Marenzi, 2004, Contrast-induced nephropathy in pateints undergoing primary angioplasty for acute myocardial infarction, J Am Coll Cardiol, 44, 1780, 10.1016/j.jacc.2004.07.043 Levy, 1996, The effect of acute renal failure on mortality: a cohort analysis, JAMA, 275, 1489, 10.1001/jama.1996.03530430033035 Katzberg, 1977, Renal renin and hemodynamic response to selective renal artery catheterization and angiography, Invest Radiol, 12, 381, 10.1097/00004424-197709000-00002 Heyman, 1988, Acute renal failure with selective medullary injury in the rat, J Clin Invest, 82, 401, 10.1172/JCI113612 Heyman, 1991, Early renal medullary hypoxic injury from radiocontrast and indomethacin, Kidney Int, 40, 632, 10.1038/ki.1991.255 Heyman, 1994, Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney, Exp Nephrol, 2, 153 Brezis, 1995, Hypoxia of the renal medulla—its implications for disease, N Engl J Med, 332, 647, 10.1056/NEJM199503093321006 Rudnick, 1997, Contrast media-associated nephrotoxicity, Semin Nephrol, 17, 15 Wang, 2000, Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism, Kidney Int, 57, 1675, 10.1046/j.1523-1755.2000.00012.x Pflueger, 2000, Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus, Mayo Clin Proc, 75, 1275, 10.4065/75.12.1275 Rudnick, 1995, The lohexol Cooperative Study. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial, Kidney Int, 45, 254, 10.1038/ki.1995.32 Barrett, 1993, Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media, Radiology, 188, 171, 10.1148/radiology.188.1.8511292 Aspelin, 2003, Nephrotoxicity in High- Risk Patients Study of Iso-osmolar and Low-Osmolar Non-ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography, N Engl J Med, 348, 491, 10.1056/NEJMoa021833 Talner, 1972, The effect of renal artery injection of contrast material on urinary enzyme excretion, Invest Radiol, 7, 311, 10.1097/00004424-197207000-00014 Liss, 1998, Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla, Kidney Int, 53, 698, 10.1046/j.1523-1755.1998.00811.x Lancelot, 2002, Effect of two dimeric iodinated contrast media on renal medullary blood perfusion and oxygenation in dogs, Invest Radiol, 37, 368, 10.1097/00004424-200207000-00002 Bakris, 1990, Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals, Am J Physiol, 258, F111 Messana, 1988, Comparison of the toxicity of the radiocontrast agents, iopamidol and diatrizoate, to rabbit renal proximal tubule cells in vitro, J Pharmacol Exp Ther, 244, 1139 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Levey, 1990, Measurement of renal function in chronic renal disease, Kidney Int, 38, 167, 10.1038/ki.1990.182 Perrone, 1992, Serun creatinine as an index of renal function: new insights into old concepts, Clin Chem, 38, 1933, 10.1093/clinchem/38.10.1933 National Kidney Foundation, 2002, KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Lamb, 2005, Estimating kidney function in adults using formulae, Ann Clin Biochem, 42, 321, 10.1258/0004563054889936 Davidson, 1989, Cardiovasular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial, Ann intern Med, 110, 119, 10.7326/0003-4819-110-2-119 Tippins, 2000, Are screening serum creatinine levels necessary prior to outpatient CT examinations?, Radiology, 216, 481, 10.1148/radiology.216.2.r00au23481 Choyke, 1998, Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?, Tech Urol, 4, 65 Olsen, 1996, Utility of the creatinine prior to intravenous contrast studies in the emergency department, J Emerg Med, 14, 543, 10.1016/S0736-4679(96)00125-4 Berns, 1989, Nephrotoxicity of contrast media, Kidney Int, 36, 730, 10.1038/ki.1989.254 Rudnick, 1994, Nephrotoxic risks of renal angiography: contrast media associated nephrotoxicity and atheroembolism—a critical review, Am J Kidney Dis, 24, 713, 10.1016/S0272-6386(12)80235-6 Rudnick, 1995, The Iohexol Cooperative Study. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial, Kidney Int, 47, 254, 10.1038/ki.1995.32 Manske, 1990, Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography, Am J Med, 89, 615, 10.1016/0002-9343(90)90180-L Rihal, 2002, Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention, Circulation, 105, 2259, 10.1161/01.CIR.0000016043.87291.33 Mehran, 2004, A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation, J Am Coll Cardiol, 44, 1393 Iakovou, 2003, Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention, J Invasive Cardiol, 15, 18 Dangas, 2005, Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables, Am J Cardiol, 95, 13, 10.1016/j.amjcard.2004.08.056 Lindsay, 2004, Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatinine kinase-MB versus rise of serum creatinine, Am J Cardiol, 94, 786, 10.1016/j.amjcard.2004.06.007 Patti, 2011, Short term, high dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN Trial), Am J Cardiol, 108, 1, 10.1016/j.amjcard.2011.03.001 Marenzi, 2004, Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction, J Am Coll Cardiol, 44, 1780, 10.1016/j.jacc.2004.07.043 Alamartine, 2003, Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations, Eur J Intern Med, 14, 426, 10.1016/j.ejim.2003.08.007 Louis, 1996, Protection from the nephrotoxicity of contrast dye, Ren Fail, 18, 639, 10.3109/08860229609047689 McCullough, 2004, Slowing the progression of diabetic nephropathy and its cardiovascular consequences, Am Heart J, 148, 243, 10.1016/j.ahj.2004.03.042 McCarthy, 1992, Multiple myeloma and contrast media, Radiology, 183, 519, 10.1148/radiology.183.2.1561361 Cigarroa, 1989, Dosing of contrast material to prevent contrast nephropathy in patients with renal disease, Am J Med, 86, 649, 10.1016/0002-9343(89)90437-3 Barrett, 1992, Contrast nephropathy in patients with impaired renal function: high versus low osmolar media, Kidney Int, 41, 1274, 10.1038/ki.1992.189 McCullough, 2001, Prediction and prevention of contrast nephropathy, J Interv Cardiol, 14, 547, 10.1111/j.1540-8183.2001.tb00371.x Freeman, 2002, Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose, Am J Cardiol, 90, 1068, 10.1016/S0002-9149(02)02771-6 Davidson, 2006, Contrast medium use, Am J Cardiol, 98, 42k, 10.1016/j.amjcard.2006.01.023 Hayami, 1996, Comparison of the nephrotoxicity between ioversol and iohexol, Int Urol Nephrol, 28, 615, 10.1007/BF02552154 Jakobsen, 1994, Renal effects of nonionic contrast media after cardioangiography, Acta Radiol, 35, 191, 10.1177/028418519403500219 McCullough, 2006, A meta-analysis of the renal safety of isomolar iodixanol compared with low-osmolar contrast media, J Am Coll Cardiol, 48, 692, 10.1016/j.jacc.2006.02.073 Mehran, 2006, A prospective, randomized, placebo-controlled trial of ioxaglate vs iodixanol in patients at increased risk for contrast nephropathy, Proceedings of Transcatheter Cardiovascular Therapeutics, 3, 10 Jo, 2006, Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: The RECOVER study: a randomized controlled trial, J Am Coll Cardiol, 48, 924, 10.1016/j.jacc.2006.06.047 Solomon, 2007, Cardiac Angiography in Renally Impaired Patients (CARE) Study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease, Circulation, 115, 3189, 10.1161/CIRCULATIONAHA.106.671644 Wessely R, Koppara T, Kastrati A, et al. Randomized clinical trial to compare the nephrotoxic effects of iso-osmolar versus low osmolar contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention: The COntrast media and NephroToxicity following coronary revascularization by angioplaSTy (CONTRAST) Study. Paper presented at SCAI-ACCi2 2008 Chicago 1 April 2008. Rudnick, 2008, Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial, Am Heart J, 156, 776, 10.1016/j.ahj.2008.05.023 Reed, 2009, The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials, J Am Coll Cardiol Intv, 2, 645, 10.1016/j.jcin.2009.05.002 Heinrich, 2009, Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials, Radiology, 250, 68, 10.1148/radiol.2501080833 Thomsen, 2008, The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography, Invest Radiol, 43, 170, 10.1097/RLI.0b013e31815f3172 Lindsay, 2003, Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine, Catheter Cardiovasc Interv, 59, 338, 10.1002/ccd.10534 Taliercio, 1986, Risks for renal dysfunction with cardiac angiography, Ann Intern Med, 104, 501, 10.7326/0003-4819-104-4-501 Miller, 1988, Intravascular contrast media: effect of dose on renal function, Radiology, 167, 607, 10.1148/radiology.167.3.3363118 Cruz, 1986, Contrast media for angiography: effect on renal function, Radiology, 158, 109, 10.1148/radiology.158.1.3079623 Eisenberg, 1980, Renal failure after major angiography, Am J Med, 68, 43, 10.1016/0002-9343(80)90163-1 Hayman, 1980, Renal consequences of rapid high dose contrast CT, AJR Am J Roentgenol, 134, 553, 10.2214/ajr.134.3.553 Ogle, 1991, Ioxaglate in paediatric angiocardiography, J Paediatr Child Health, 27, 282, 10.1111/j.1440-1754.1991.tb02538.x Older, 1976, Angiographically-induced renal failure and its radiographic detection, AJR Am J Roentgenol, 126, 1039, 10.2214/ajr.126.5.1039 Parfrey, 1989, Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study, N Engl J Med, 320, 143, 10.1056/NEJM198901193200303 Swartz, 1978, Renal failure following major angiography, Am J Med, 65, 31, 10.1016/0002-9343(78)90689-7 Zuckerman, 1996, Safety of pulmonary angiography in the 1990s, J Vasc Interv Radiol, 7, 199, 10.1016/S1051-0443(96)70762-5 Laskey, 2007, NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: pharmacokinetically-based risk factor for prediction of early creatinine increase after percutaneous coronary intervention, J Am Coll Cardiol, 50, 584, 10.1016/j.jacc.2007.03.058 Vlietstra, 1996, Contrast nephropathy after coronary angioplasty in chronic renal insufficiency, Am Heart J, 132, 1049, 10.1016/S0002-8703(96)90021-6 Campbell, 1990, A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography, Can Assoc Radiol J, 41, 133 Chanard, 1991, Nephrotoxicity of conventional and low osmolality radiocontrast media, J Nephrol, 4, 203 Krumlovsky, 1978, Acute renal failure: association with administration of radiographic contrast material, JAMA, 239, 125, 10.1001/jama.1978.03280290045019 Guitterez, 2002, Determinants of serum creatinine trajectory in acute contrast nephropathy, J Interv Cardiol, 15, 349, 10.1111/j.1540-8183.2002.tb01067.x Sutton, 2002, Microvascular endothelial injury and dysfunction during ischemic acute renal failure, Kidney Int, 62, 1539, 10.1046/j.1523-1755.2002.00631.x Ailawadi, 2003, Gadolinium as a non-nephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia, J Vasc Surg, 37, 346, 10.1067/mva.2003.51 Bellin, 1992, Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure, Magn Reson Imaging, 10, 115, 10.1016/0730-725X(92)90380-I Hammer, 1999, Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography, Eur Radiol, 9, 128, 10.1007/s003300050643 Hammer, 2000, Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure, Transplant Proc, 32, 432, 10.1016/S0041-1345(00)00840-X Haustein, 1992, Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure, Invest Radiol, 27, 153, 10.1097/00004424-199202000-00012 Briguori, 2006, Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures, Catheter Cardiovasc Interv, 67, 175, 10.1002/ccd.20592 Kessel, 2002, Carbon-dioxide-guided vascular interventions: technique and pitfalls, Cardiovasc Intervent Radiol, 25, 476, 10.1007/s00270-002-1925-x Beese, 2000, Renal angiography using carbon dioxide, Br J Radiol, 73, 3, 10.1259/bjr.73.865.10721312 Erley, 1999, Does hydration prevent radiocontrast-induced acute renal failure?, Nephrol Dial Transplant, 14, 1064, 10.1093/ndt/14.5.1064 Vari, 1988, Induction, prevention and mechanisms of contrast media-induced acute renal failure, Kidney Int, 33, 699, 10.1038/ki.1988.55 Solomon, 1994, Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents, N Engl J Med, 331, 1416, 10.1056/NEJM199411243312104 Weisberg, 1994, Risk of radiocontrast nephropathy in patients with and without diabetes mellitus, Kidney Int, 45, 259, 10.1038/ki.1994.32 Kurnik, 1998, Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy, Am J Kidney Dis, 33, 674, 10.1053/ajkd.1998.v31.pm9531185 Stone, 2003, Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial, JAMA, 290, 2284, 10.1001/jama.290.17.2284 Trivedi, 2003, A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity, Nephron Clin Pract, 93, C29, 10.1159/000066641 Taylor, 1998, PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction, Chest, 114, 1570, 10.1378/chest.114.6.1570 Bader, 2004, What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?, Clin Nephrol, 62, 1, 10.5414/CNP62001 Stevens, 1999, A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE Study–Prevention of Radiocontrast-induced Nephropathy Clinical Evaluation, J Am Coll Cardiol, 33, 403, 10.1016/S0735-1097(98)00574-9 Mueller, 2002, Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1,620 patients undergoing coronary angioplasty, Arch Intern Med, 162, 329, 10.1001/archinte.162.3.329 Nikolsky, 2008, Hydration protocols to reduce the incidence of contrast-induced nephropathy, J Invasive Cardiol, 20, 527 Krasuski, 2003, Optimal timing of hydration to decrease contrast-associated nephropathy: the OTHER CAN Study, J Invasive Cardiol, 15, 699 Dussol, 2006, A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients, Nephrol Dial Transplant, 21, 2120, 10.1093/ndt/gfl133 Merten, 2004, Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial, JAMA, 291, 2328, 10.1001/jama.291.19.2328 Hogan, 2008, Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis, Am Heart J, 156, 414, 10.1016/j.ahj.2008.05.014 Joannidis, 2008, Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis, Wien Klin Wochenschr, 120, 742, 10.1007/s00508-008-1117-z Navaneethan, 2009, Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis, Am J Kidney Dis, 53, 617, 10.1053/j.ajkd.2008.08.033 Meier, 2009, Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis, BMC Med, 7, 23, 10.1186/1741-7015-7-23 Sterner, 2000, Does post-angiographic hemodialysis reduce the risk of contrast medium nephropathy?, Scand J Urol Nephrol, 34, 323, 10.1080/003655900750048350 Marenzi, 2003, The prevention of radiocontrast-agent-induced nephropathy by hemofiltration, N EngI J Med, 349, 1333, 10.1056/NEJMoa023204 Pucelikova, 2008, Contrast-induced nephropathy, Catheter Cardiovasc Interv, 71, 62, 10.1002/ccd.21207 Briguori, 2004, Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity, Eur Heart J, 25, 206, 10.1016/j.ehj.2003.11.016 Baker, 2003, A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study, J Am Coll Cardiol, 41, 2114, 10.1016/S0735-1097(03)00487-X Hoffmann, 2004, The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable, J Am Soc Nephrol, 15, 407, 10.1097/01.ASN.0000106780.14856.55 Birck, 2003, Acetylcysteine for prevention of contrast nephropathy: meta-analysis, Lancet, 362, 598, 10.1016/S0140-6736(03)14189-X Isenbarger, 2003, Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy, Am J Cardiol, 92, 1454, 10.1016/j.amjcard.2003.08.059 Alonso, 2004, Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials, Am J Kidney Dis, 43, 1, 10.1053/j.ajkd.2003.09.009 Bagshaw, 2004, Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis, BMC Med, 2, 38, 10.1186/1741-7015-2-38 Pannu, 2004, Systematic review of the impact of N-acetylcysteine on contrast nephropathy, Kidney Int, 65, 1366, 10.1111/j.1523-1755.2004.00516.x Kshirsagar, 2004, N-Acetylcysteine for the prevention of radiocontrast-induced nephropathy: a meta-analysis of prospective controlled trials, J Am Soc Nephrol, 15, 761, 10.1097/01.ASN.0000116241.47678.49 Nallamothu, 2004, Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis, Am J Med, 117, 938, 10.1016/j.amjmed.2004.06.046 Liu, 2005, N-Acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis, J Gen Intern Med, 20, 193, 10.1111/j.1525-1497.2005.30323.x Duong, 2005, N-Acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis, Catheter Cardiovasc Interv, 64, 471, 10.1002/ccd.20342 Guru, 2004, The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy, Clin Nephrol, 62, 77, 10.5414/CNP62077 Misra, 2004, Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis, Clin Cardiol, 27, 607, 10.1002/clc.4960271106 Zagler, 2006, N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials, Am Heart J, 151, 140, 10.1016/j.ahj.2005.01.055 Kelly, 2008, Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy, Ann Intern Med, 148, 284, 10.7326/0003-4819-148-4-200802190-00007 Brown, 2009, Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis, JACC Cardiovasc Interv, 2, 1116, 10.1016/j.jcin.2009.07.015 Pflueger, 2000, Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus, Mayo Clin Proc, 75, 1275, 10.4065/75.12.1275 Erley, 1994, Adenosine antagonist theophylline prevents the reduction of glomeruiar filtration after contrast media application, Kidney Int, 45, 1425, 10.1038/ki.1994.186 Davignon, 2004, Beneficial cardiovascular pleiotropic effects of statins, Circulation, 109, III39, 10.1161/01.CIR.0000131517.20177.5a Attallah, 2004, The potential role of statins in contrast nephropathy, Clin Nephrol, 62, 273, 10.5414/CNP62273 Khanal, 2005, Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions, Am J Med, 118, 843, 10.1016/j.amjmed.2005.03.031 Jo, 2008, Prevention of Radiocontrast Medium-induced Nephropathy using Short-term High dose Simvastatin in Patients with Renal Insufficiency Undergoing Coronary Angiography (PROMISS) Trial: a randomized controlled study, Am Heart J, 155, 499.e1, 10.1016/j.ahj.2007.11.042 Spargias, 2004, Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention, Circulation, 110, 2837, 10.1161/01.CIR.0000146396.19081.73 Briguori, 2007, Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies, Circulation, 115, 1211, 10.1161/CIRCULATIONAHA.106.687152 Kapoor, 1996, Use of dopamine in prevention of contrast-induced acute renal failure: a randomised study, Int J Cardiol, 53, 233, 10.1016/0167-5273(95)02547-2 Gare, 1999, The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography, J Am Coll Cardiol, 34, 1682, 10.1016/S0735-1097(99)00422-2 Abizaid, 1999, Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency, Am J Cardiol, 83, 260, 10.1016/S0002-9149(98)00833-9 Allaqaband, 2002, Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy, Catheter Cardiovasc Interv, 57, 279, 10.1002/ccd.10323 Sampath S, Moran JL, Graham PL, et al. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med 2007 (Publish ahead of print). Bagshaw, 2007, Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis, Crit Care Resusc, 9, 60 Townsend, 2008, New insights on intravenous fluids, diuretics and acute kidney injury, Nephron Clin Pract, 109, c106, 10.1159/000142930 Mehta, 2002, Diuretics, mortality, and nonrecovery of renal function in acute renal failure, JAMA, 288, 2547, 10.1001/jama.288.20.2547 Lewis, 2000, Anaritide Acute Renal Failure Study Group. Atrial natriuretic factor in oliguric acute renal failure, Am J Kidney Dis, 36, 767, 10.1053/ajkd.2000.17659 Meyer, 1999, Therapeutic use of the natriuretic peptide ularitide in acute renal failure, Ren Fail, 21, 85, 10.3109/08860229909066972 Cacoub, 1988, No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure, Clin Nephrol, 29, 215 Khoury, 1995, The effect of prophylactic nifedipine on renal function in patients administered contrast media, Pharmacotherapy, 15, 59 Russo, 1990, Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker, Nephron, 55, 254, 10.1159/000185971 Madsen, 1998, Effect of nitrendipine on renal function and on hormonal parameters after intravascular iopromide, Acta Radiol, 39, 375, 10.1080/02841859809172448 Carraro, 1996, Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration, Nephrol Dial Transplant, 11, 444, 10.1093/oxfordjournals.ndt.a027309 Neumayer, 1989, Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial, Nephrol Dial Transplant, 4, 1030 Spangberg-Viklund, 1996, Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?, Scand J Urol Nephrol, 30, 63, 10.3109/00365599609182351 Arici, 2003, Radiocontrast-induced nephrotoxicity and urinary alpha glutathione S-transferase levels: effect of amlodipine administration, Int Urol Nephrol, 35, 255, 10.1023/B:UROL.0000020186.72345.ec Ng, 2006, Selective renal arterial infusion of fenoldopan for the prevention of contrast-indued nephropathy, J Interv Cardiol, 19, 75, 10.1111/j.1540-8183.2006.00108.x Teirstein, 2006, Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization, Am J Cardiol, 97, 1076, 10.1016/j.amjcard.2005.10.053 Allie, 2008, Contrast-induced nephropathy and targeted renal therapy in peripheral vascular disease: an 18-month experience, Am J Cardiol, 102, 226 Allie, 2008, Targeted renal therapy in high risk cardiac surgery: early safety and feasibility with a novel catheter treatment for renal function preservation during high risk coronary artery bypass grafting, Am J Cardiol, 102, 118i Weisz, 2009, Safety and performance of targeted renal therapy: the Be-RITe!, Registry. J Endovasc Ther, 16, 1, 10.1583/08-2515.1 Thomsen, 2006, ESUR guidelines on contrast media, Abdom Imaging, 31, 131, 10.1007/s00261-005-0380-y